Potential Therapeutic Use of PPARgamma-Programed Human Monocyte-Derived Dendritic Cells in Cancer Vaccination Therapy.

Abstract:

:Dendritic cells (DCs) can regulate all elements of the immune system, and therefore are an ideal target for vaccination. During the last two decades, as a result of extensive research, DCs became the primary target of antitumor vaccination as well. A critical issue of antitumor vaccination is the phenotype of the dendritic cell used. It has been recently shown that several nuclear hormone receptors, and amongst them the lipid-activated nuclear receptor and peroxisome proliferator-activated receptor gamma (PPARgamma), have important roles in effecting the immunophenotype of human dendritic cells. It regulates primarily lipid metabolism and via this it influences the immunophenotype of DCs by altering lipid antigen uptake, presentation, and also other immune functions. In this review, we summarize the principles of antitumor vaccination strategies and present our hypothesis on how PPARgamma-regulated processes might be involved and could be exploited in the design of vaccination strategies.

journal_name

PPAR Res

journal_title

PPAR research

authors

Gyöngyösi A,Nagy L

doi

10.1155/2008/473804

subject

Has Abstract

pub_date

2008-01-01 00:00:00

pages

473804

eissn

1687-4757

issn

1687-4765

journal_volume

2008

pub_type

杂志文章
  • Therapeutic Potential of PPARγ Activation in Stroke.

    abstract::Stroke (focal cerebral ischemia) is a leading cause of death and disability among adult population. Many pathological events including inflammation and oxidative stress during the acute period contributes to the secondary neuronal death leading the neurological dysfunction after stroke. Transcriptional regulation of g...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/461981

    authors: Vemuganti R

    更新日期:2008-01-01 00:00:00

  • The Role of PPARs in Placental Immunology: A Systematic Review of the Literature.

    abstract::Pregnancy is a state of immunotolerance, and pregnancy outcome is strongly linked to the correct activation and balancing of the maternal immune system. Besides abortion as possible result of improper early pregnancy development, other pregnancy associated conditions like preeclampsia (PE), intrauterine growth retarda...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2013/970276

    authors: Hutter S,Knabl J,Andergassen U,Jeschke U

    更新日期:2013-01-01 00:00:00

  • The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma.

    abstract::Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of the women of reproductive age. Familial clustering of PCOS has been consistently reported suggesting that genetic factors play a role in the development of the syndrome although PCOS cases do not exhibit a clear pattern of Mendelian inheritance....

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2007/49109

    authors: Unluturk U,Harmanci A,Kocaefe C,Yildiz BO

    更新日期:2007-01-01 00:00:00

  • Inhibition of Protein Farnesylation Arrests Adipogenesis and Affects PPARgamma Expression and Activation in Differentiating Mesenchymal Stem Cells.

    abstract::Protein farnesylation is required for the activation of multiple proteins involved in cell differentiation and function. In white adipose tissue protein, farnesylation has shown to be essential for the successful differentiation of preadipocytes into adipocytes. We hypothesize that protein farnesylation is required fo...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2007/81654

    authors: Rivas D,Akter R,Duque G

    更新日期:2007-01-01 00:00:00

  • PPAR Action in Human Placental Development and Pregnancy and Its Complications.

    abstract::During pregnancy crucial anatomic, physiologic, and metabolic changes challenge the mother and the fetus. The placenta is a remarkable organ that allows the mother and the fetus to adapt to the new metabolic, immunologic, and angiogenic environment imposed by gestation. One of the physiologic systems that appears to h...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/527048

    authors: Wieser F,Waite L,Depoix C,Taylor RN

    更新日期:2008-01-01 00:00:00

  • Association of PPAR Alpha Intron 7 G/C, PPAR Gamma 2 Pro12Ala, and C161T Polymorphisms with Serum Fetuin-A Concentrations.

    abstract:BACKGROUND:Both peroxisome activator proteins (PPARs) and fetuin-A play a role in lipid and glucose metabolism. AIMS:We investigated whether PPARα intron 7 G2468/C and PPARγ2 Pro12Ala and PPARγ exon 6 C161T polymorphisms are associated with serum fetuin-A concentrations. PATIENTS AND METHODS:The PPARα intron 7 G/C po...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2017/7636019

    authors: Márkus B,Vörös K,Supák D,Melczer Z,Cseh K,Kalabay L

    更新日期:2017-01-01 00:00:00

  • Fenofibrate enhances the in vitro differentiation of foxp3(+) regulatory T cells in mice.

    abstract::Foxp3(+) regulatory T cells (Tregs) play a critical role in maintaining immune self-tolerance. Reduced number and activity of Tregs are usually found in autoimmune and inflammatory diseases, and enhancing the differentiation of Tregs may be a promising therapeutic strategy. Some reports suggested an anti-inflammatory ...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2012/529035

    authors: Zhou Z,Liang Y,Gao Y,Kong W,Feng J,Wang X

    更新日期:2012-01-01 00:00:00

  • Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?

    abstract::Glioblastoma multiforme (GBM) represents one of the most frequent malignant brain tumors. Current therapies do not provide real solutions to this pathology. Their failure can be ascribed to a cell subpopulation with stem-like properties called glioma stem cells (GSCs). Therefore, new therapeutic strategies GSC-targete...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2016/7175067

    authors: Cilibrasi C,Butta V,Riva G,Bentivegna A

    更新日期:2016-01-01 00:00:00

  • PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive Agents.

    abstract::Peroxisome proliferator-activated receptor-gamma (PPARgamma), one of three ligand-activated transcription factors named PPAR, has been identified as a molecular target for cancer chemopreventive agents. PPARgamma was initially understood as a regulator of adipocyte differentiation and glucose homeostasis while later o...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/436489

    authors: Sainis I,Vareli K,Karavasilis V,Briasoulis E

    更新日期:2008-01-01 00:00:00

  • Activation of PPARγ by Rosiglitazone does not negatively impact male sex steroid hormones in diabetic rats.

    abstract::Peroxisome proliferator-activated receptor gamma (PPARγ) activation decreased serum testosterone (T) in women with hyperthecosis and/or polycystic ovary syndrome and reduced the conversion of androgens to estradiol (E2) in female rats. This implies modulation of female sex steroid hormones by PPARγ. It is not clear if...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2009/101857

    authors: Mansour M,Coleman E,Dennis J,Akingbemi B,Schwartz D,Braden T,Judd R,Plaisance E,Stewart LK,Morrison E

    更新日期:2009-01-01 00:00:00

  • HMGB1 Is Involved in the Protective Effect of the PPAR α Agonist Fenofibrate against Cardiac Hypertrophy.

    abstract::High mobility group box 1 (HMGB1) is a ubiquitous nuclear DNA-binding protein whose function is dependent on its cellular location. Extracellular HMGB1 is regarded as a delayed mediator of proinflammatory cytokines for initiating and amplifying inflammatory responses, whereas nuclear HMGB1 has been found to prevent ca...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2014/541394

    authors: Jia Z,Xue R,Liu G,Li L,Yang J,Pi G,Ma S,Kan Q

    更新日期:2014-01-01 00:00:00

  • Pparg may Promote Chemosensitivity of Hypopharyngeal Squamous Cell Carcinoma.

    abstract::The upregulation of peroxisome proliferator-activated receptor gamma (PPARG) has been shown to increase the chemosensitivity of several human cancers. This study is aimed at studying if PPARG sensitizes hypopharyngeal squamous cell carcinoma (HSCC) in chemotherapeutic treatments and at dissecting possible mechanisms o...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2020/6452182

    authors: Lian M,Chen J,Shen X,Hou L,Fang J

    更新日期:2020-04-22 00:00:00

  • PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia.

    abstract::Irisin is related to insulin resistance and metabolic disorders. The physiologic effects of irisin are partially mediated through peroxisome proliferator-activated receptor-α (PPAR-α). We investigated the effect of fenofibrate, a PPAR-α agonist, on serum irisin in type 2 diabetes patients with hypertriglyceridemia. Th...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2015/924131

    authors: Feng X,Gao X,Jia Y,Zhang H,Pan Q,Yao Z,Yang N,Liu J,Xu Y,Wang G,Yang X

    更新日期:2015-01-01 00:00:00

  • Downregulation of the proinflammatory state of circulating mononuclear cells by short-term treatment with pioglitazone in patients with type 2 diabetes mellitus and coronary artery disease.

    abstract::Background. This study was performed to investigate the influence of a short-term treatment with pioglitazone versus placebo on inflammatory activation of mononuclear cells (mRNA expression/protein secretion of inflammatory markers). Methods and Results. Sixty-three patients with well-controlled type 2 diabetes (52 ma...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2011/647017

    authors: Pfützner A,Weise A,Pfützner-Riehn E,Lübben G,Morcos M,Karagiannis E,Weber M,Forst T

    更新日期:2011-01-01 00:00:00

  • Vascular Remodeling, Oxidative Stress, and Disrupted PPARγ Expression in Rats of Long-Term Hyperhomocysteinemia with Metabolic Disturbance.

    abstract::Hyperhomocysteinemia, a risk factor for vascular disease, is associated with metabolic syndrome. Our study was aimed at exploring the effect of long-term hyperhomocysteinemia with metabolic disturbances on vascular remodeling. We also studied oxidative stress and expression of PPARγ in the coronary arteriole as a poss...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2018/6738703

    authors: Huo Y,Wu X,Ding J,Geng Y,Qiao W,Ge A,Guo C,Lv J,Bao H,Fan W

    更新日期:2018-01-15 00:00:00

  • Nicotinic acid-mediated activation of both membrane and nuclear receptors towards therapeutic glucocorticoid mimetics for treating multiple sclerosis.

    abstract::Acute attacks of multiple sclerosis (MS) are most commonly treated with glucocorticoids, which can provide life-saving albeit only temporary symptomatic relief. The mechanism of action (MOA) is now known to involve induction of indoleamine 2,3-dioxygenase (IDO) and interleukin-10 (IL-10), where IL-10 requires subseque...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2009/853707

    authors: Penberthy WT

    更新日期:2009-01-01 00:00:00

  • PPAR-gamma Signaling Crosstalk in Mesenchymal Stem Cells.

    abstract::Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a member of the nuclear receptor (NR) superfamily of ligand-activated transcriptional factors. Among other functions, PPAR-gamma acts as a key regulator of the adipogenesis. Since several cytokines (IL-1, TNF-alpha, TGF-beta) had been known to inhibit ad...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2010/341671

    authors: Takada I,Kouzmenko AP,Kato S

    更新日期:2010-01-01 00:00:00

  • Inhibition of Carrageenan-Induced Cutaneous Inflammation by PPAR Agonists Is Dependent on Hepatocyte-Specific Retinoid X ReceptorAlpha.

    abstract::It has been proposed that PPAR-dependent, accelerated catabolism of proinflammatory mediators may contribute to the fast resolution of inflammation. Because retinoid X receptors are obligate heterodimer partners of PPARs, we investigated the impact of deleting hepatocyte-specific RXRalpha on the antiedema effect of PP...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/PPAR/2006/96341

    authors: Wan YJ,Badr MZ

    更新日期:2006-01-01 00:00:00

  • Peroxisome proliferator activated receptor ligands as regulators of airway inflammation and remodelling in chronic lung disease.

    abstract::Inflammation is a major component in the pathology of chronic lung diseases, including asthma. Anti-inflammatory treatment with corticosteroids is not effective in all patients. Thus, new therapeutic options are required to control diverse cellular functions that are currently not optimally targeted by these drugs in ...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2007/14983

    authors: Ward JE,Tan X

    更新日期:2007-01-01 00:00:00

  • The Effect of PPAR Agonists on the Migration of Mature and Immature Eosinophils.

    abstract::PPARγ agonists can either enhance or inhibit eosinophil migration, which is a sum of directional migration (chemotaxis) and random cell movement (chemokinesis). To date, the effects of PPAR agonists on chemokinesis have not been examined. This study investigates the effects of PPARα, δ, and γ agonists on eosinophil mi...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2012/235231

    authors: Smith SG,Imaoka H,Punia N,Irshad A,Janssen LL,Sehmi R,Gauvreau GM

    更新日期:2012-01-01 00:00:00

  • Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice.

    abstract::Aster glehni is well known for its therapeutic properties. This study was performed to investigate the effects of A. glehni on nonalcoholic fatty liver disease (NAFLD) in atherosclerotic condition, by determining the levels of biomarkers related to lipid metabolism and inflammation in serum, liver, and adipose tissue....

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2017/3912567

    authors: Lee YJ,Jang YN,Han YM,Kim HM,Jeong JM,Son MJ,Jin CB,Kim HJ,Seo HS

    更新日期:2017-01-01 00:00:00

  • Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions.

    abstract::To investigate the effects of fimasartan on nonalcoholic fatty liver disease in hyperlipidemic and hypertensive conditions, the levels of biomarkers related to fatty acid metabolism were determined in HepG2 and differentiated 3T3-L1 cells treated by high fatty acid and liver and visceral fat tissue samples of spontane...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2017/8048720

    authors: Lee YJ,Jang YN,Han YM,Kim HM,Jeong JM,Seo HS

    更新日期:2017-01-01 00:00:00

  • Activated PPARgamma Targets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma Cells.

    abstract::Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belonging to the nuclear hormone receptor superfamily. Their discovery in the 1990s provided insights into the cellular mechanisms involved in the control of energy homeostasis, the regulation of cell differentiation, prolif...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/254108

    authors: Han SW,Roman J

    更新日期:2008-01-01 00:00:00

  • Peroxisome Proliferator-Activated Receptor Delta: A Conserved Director of Lipid Homeostasis through Regulation of the Oxidative Capacity of Muscle.

    abstract::The peroxisome proliferator-activated receptors (PPARs), which are ligand-inducible transcription factors expressed in a variety of tissues, have been shown to perform key roles in lipid homeostasis. In physiological situations such as fasting and physical exercise, one PPAR subtype, PPARdelta, triggers a transcriptio...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/172676

    authors: de Lange P,Lombardi A,Silvestri E,Goglia F,Lanni A,Moreno M

    更新日期:2008-01-01 00:00:00

  • Diet Modifies Pioglitazone's Influence on Hepatic PPARγ-Regulated Mitochondrial Gene Expression.

    abstract::Pioglitazone (Pio) is a thiazolidinedione (TZD) insulin-sensitizing drug whose effects result predominantly from its modulation of the transcriptional activity of peroxisome proliferator-activated-receptor-gamma (PPARγ). Pio is used to treat human insulin-resistant diabetes and also frequently considered for treatment...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2020/3817573

    authors: Kulkarni S,Huang J,Tycksen E,Cliften PF,Rudnick DA

    更新日期:2020-09-10 00:00:00

  • Involvement of the Retinoid X Receptor Ligand in the Anti-Inflammatory Effect Induced by Peroxisome Proliferator-Activated Receptor γ Agonist In Vivo.

    abstract::Peroxisome proliferator-activated receptor γ (PPARγ) forms a heterodimeric DNA-binding complex with retinoid X receptors (RXRs). It has been reported that the effect of the PPAR agonist is reduced in hepatocyte RXR-deficient mice. Therefore, it is suggested that the endogenous RXR ligand is involved in the PPARγ agoni...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2011/840194

    authors: Yamamoto A,Kakuta H,Miyachi H,Sugimoto Y

    更新日期:2011-01-01 00:00:00

  • The PPAR Ω Pocket: Renewed Opportunities for Drug Development.

    abstract::The past decade of PPARγ research has dramatically improved our understanding of the structural and mechanistic bases for the diverging physiological effects of different classes of PPARγ ligands. The discoveries that lie at the heart of these developments have enabled the design of a new class of PPARγ ligands, capab...

    journal_title:PPAR research

    pub_type: 杂志文章,评审

    doi:10.1155/2020/9657380

    authors: Kaupang Å,Hansen TV

    更新日期:2020-07-01 00:00:00

  • Inhibitors of Fatty Acid Synthesis Induce PPAR α -Regulated Fatty Acid β -Oxidative Genes: Synergistic Roles of L-FABP and Glucose.

    abstract::While TOFA (acetyl CoA carboxylase inhibitor) and C75 (fatty acid synthase inhibitor) prevent lipid accumulation by inhibiting fatty acid synthesis, the mechanism of action is not simply accounted for by inhibition of the enzymes alone. Liver fatty acid binding protein (L-FABP), a mediator of long chain fatty acid sig...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2013/865604

    authors: Huang H,McIntosh AL,Martin GG,Petrescu AD,Landrock KK,Landrock D,Kier AB,Schroeder F

    更新日期:2013-01-01 00:00:00

  • The role of peroxisome proliferator-activated receptors in colorectal cancer.

    abstract::Colorectal cancer is one of the most common cancers in the world. Dietary fat intake is a major risk factor for colorectal cancer. Some nuclear hormone receptors play an important role in regulating nutrient metabolism and energy homeostasis. Among these receptors, special attention has been focused on the role of per...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2012/876418

    authors: Park JI,Kwak JY

    更新日期:2012-01-01 00:00:00

  • PPARs Expression in Adult Mouse Neural Stem Cells: Modulation of PPARs during Astroglial Differentiaton of NSC.

    abstract::PPAR isotypes are involved in the regulation of cell proliferation, death, and differentiation, with different roles and mechanisms depending on the specific isotype and ligand and on the differentiated, undifferentiated, or transformed status of the cell. Differentiation stimuli are integrated by key transcription fa...

    journal_title:PPAR research

    pub_type: 杂志文章,收录出版

    doi:10.1155/2007/48242

    authors: Cimini A,Cristiano L,Benedetti E,D'Angelo B,Cerù MP

    更新日期:2007-01-01 00:00:00